VOGLI RPD 3/.05 10 S

About

VOGLI RPD 3/.05 is a combination medication indicated for the management of type 2 diabetes mellitus, typically combining an alpha-glucosidase inhibitor (like Voglibose) and a thiazolidinedione (like Pioglitazone). This dual-action therapy addresses different aspects of glucose metabolism. Voglibose works by delaying the digestion and absorption of carbohydrates from the gut, thereby reducing postprandial blood glucose spikes. Pioglitazone, on the other hand, improves insulin sensitivity in peripheral tissues and the liver, allowing the body's own insulin to work more effectively. This synergistic effect helps to achieve better overall glycemic control.

This formulation is prescribed for adult patients whose blood sugar levels are not adequately controlled by monotherapy with either component, or when a combination approach is deemed appropriate by a healthcare provider. The primary goal is to lower HbA1c levels, manage both fasting and post-meal blood glucose, and ultimately reduce the risk of long-term diabetic complications. Regular monitoring of blood glucose, HbA1c, and liver function tests is important to ensure the medication's effectiveness and safety profile.

Uses

• Management of type 2 diabetes mellitus.
• Improved glycemic control in adults.
• Reduction of postprandial blood glucose levels.
• When monotherapy is insufficient.

Directions For Use

Take this medication orally with meals, as directed by your physician. Do not crush or chew the tablets.

Benefits

• Effective control of blood glucose levels.
• Significant reduction in HbA1c levels.
• Improved insulin sensitivity.
• Effective management of post-meal sugar spikes.
• Reduced risk of long-term diabetic complications.
• Dual mechanism of action for comprehensive control.

Side Effects

• Nausea
• Diarrhea
• Abdominal pain
• Flatulence
• Headache
• Dizziness
• Weight gain
• Fluid retention/Edema
• Upper respiratory tract infection
• Bone fractures (with Pioglitazone)
• Visual disturbances
• Anemia

Safety Measures

• Alcohol - Use alcohol with caution as it can affect blood sugar levels. No direct interaction with the medication components, but general diabetic advice applies.
• Pregnancy - Generally not recommended during pregnancy. Consult your doctor; insulin is often preferred for glycemic control in pregnant women.
• Breastfeeding - Not recommended during breastfeeding as components may pass into breast milk and potentially affect the infant.
• Liver - Contraindicated in active liver disease due to Pioglitazone. Use with caution in patients with liver impairment; regular monitoring of liver enzymes is advised.
• Kidney - Use with caution in patients with severe kidney conditions, particularly due to the fluid retention risk associated with Pioglitazone.
• Lung - Use with caution in patients with severe lung conditions, especially if there is a risk of fluid retention or exacerbation of heart failure.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.